The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Anti-cancer chalcones: Structural and molecular target perspectives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Lodish, H. F. (1986) · Cited by 5,650
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,560
Mitotic kinases as regulators of cell division and its checkpoints
Nigg, E. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048096 · Cited by 1,547
Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J., & Su, B. (2006) · Cell · doi:10.1016/j.cell.2006.08.033 · Cited by 1,410
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276
Hauf, S., Cole, R. W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van Meel, J., Rieder, C. L., & Peters, J.-M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200208092 · Cited by 1,155
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,042
Proteasome inhibitors in cancer therapy
Manasanch, E. E., & Orlowski, R. Z. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.206 · Cited by 1,024
The role of histone deacetylases (HDACs) in human cancer
Ropero, S., & Esteller, M. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.001 · Cited by 997
Harrington, E. A., Bebbington, D., Moore, J., Rasmussen, R. K., Ajose-Adeogun, A. O., Nakayama, T., Graham, J. A., Demur, C., Hercend, T., Diu-Hercend, A., et al. (2004) · Nature Medicine · doi:10.1038/nm1003 · Cited by 965
ErbB receptors and signaling pathways in cancer
Hynes, N. E., & MacDonald, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.010 · Cited by 956
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
Arvin, A. M., Campadelli‐Fiume, G., Mocarski, E. S., Moore, P. S., Roizman, B., Whitley, R. J., & Yamanishi, K. (2007) · Cited by 844
Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles
Glover, D. M., Leibowitz, M. H., McLean, D. A., & Parry, H. (1995) · Cell · doi:10.1016/0092-8674(95)90374-7 · Cited by 836
Thompson, M. P., & Kurzrock, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0670-3 · Cited by 786
Human ATP-binding cassette (ABC) transporter family
Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-281 · Cited by 780
Harris, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00105-2 · Cited by 776
Treatment of metastatic melanoma: an overview.
Bhatia, S., Tykodi, S. S., & Thompson, J. A. (2009) · PubMed · Cited by 666
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Abrams, S. L., Lee, J. T., Chang, F., Bertrand, F. E., Navolanic, P. M., Terrian, D. M., Franklin, R. A., D’Assoro, A. B., et al. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.004 · Cited by 664
(1987) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(87)90055-3 · Cited by 640
The angiogenic switch in carcinogenesis
Baeriswyl, V., & Christofori, G. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.05.003 · Cited by 625
Dimmock, J. R., Elias, D. W., Beazely, M. A., & Kandepu, N. M. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401182509 · Cited by 599
Tumor Suppressive Functions of p53
Zilfou, J. T., & Lowe, S. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001883 · Cited by 575
Adams, R. R., Maiato, H., Earnshaw, W. C., & Carmena, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.4.865 · Cited by 453
Cell cycle regulation by the Cdc25 phosphatase family
Nilsson, I., & Hoffmann, I. (2000) · Progress in Cell Cycle Research · doi:10.1007/978-1-4615-4253-7_10 · Cited by 450
Harrison, D. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011205 · Cited by 417
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Natarajan, K., Xie, Y., Baer, M. R., & Ross, D. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.002 · Cited by 405
Catalytic topoisomerase II inhibitors in cancer therapy
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00058-5 · Cited by 398
Miranda, C. L., Stevens, J. F., Helmrich, A., Henderson, M. C., Rodriguez, R. J., Yang, Y.-H., Deinzer, M. L., Barnes, D. W., & Buhler, D. R. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00019-8 · Cited by 397
Goodman and Gilman's Manual of Pharmacology and Therapeutics
Goodman, L., Gilman, A. G., Brunton, L. L., & Parker, K. L. (2007) · Cited by 396
Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation
Pruitt, K., Zinn, R. L., Ohm, J. E., McGarvey, K. M., Kang, S.-H. L., Watkins, D. N., Herman, J. G., & Baylin, S. B. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020040 · Cited by 387
Mammalian Sirt1: insights on its biological functions
Rahman, S., & Islam, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-11 · Cited by 362
Flavonoids and Cancer Prevention: A Review of the Evidence
Romagnolo, D. F., & Selmin, O. I. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.702534 · Cited by 354
The role of chalcones in suppression of NF-κB-mediated inflammation and cancer
Yadav, V. R., Prasad, S., Sung, B., & Aggarwal, B. B. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.006 · Cited by 339
The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
Azzouni, F., Godoy, A., Li, Y., & Mohler, J. (2012) · Advances in Urology · doi:10.1155/2012/530121 · Cited by 333
Chen, Y., Clegg, N. J., & Scher, H. I. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70229-3 · Cited by 324
Tatsuka, M., Katayama, H. G., Ota, T., Tanaka, T., Odashima, S., Suzuki, F., & Terada, Y. (1998) · PubMed · Cited by 319
The cdc25B phosphatase is essential for the G 2/M phase transition in human cells
Lammer1, C., Wagerer, S., Saffrich, R., Mertens, D., Ansorge, W., & Hoffmann, I. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.16.2445 · Cited by 306
Design, Synthesis, and Evaluation of Novel Boronic-Chalcone Derivatives as Antitumor Agents
Kumar, S. K., Hager, E., Pettit, C., Gurulingappa, H., Davidson, N. E., & Khan, S. R. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030213+ · Cited by 303
Nakanishi, T., & Ross, D. D. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10320 · Cited by 301
Proteasome inhibitors in cancer therapy
Crawford, L. J., Walker, B., & Irvine, A. E. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0121-7 · Cited by 299
Epstein-Barr virus–associated lymphoproliferative disorders
Rezk, S. A., & Weiss, L. M. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.05.020 · Cited by 298
ABCG2 – a transporter for all seasons
Sarkadi, B., Özvegy-Laczka, C., Német, K., & Váradi, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.123 · Cited by 282
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang, L., Cunningham, J. M., Winters, J. L., Guenther, J. C., French, A. J., Boardman, L. A., Burgart, L. J., McDonnell, S. K., Schaid, D. J., & Thibodeau, S. N. (2003) · PubMed · Cited by 282
Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53
Stoll, R., Renner, C., Hansen, S., Palme, S., Klein, C., Belling, A., Zeslawski, W., Kamionka, M., Rehm, T., Mühlhahn, P., et al. (2001) · Biochemistry · doi:10.1021/bi000930v · Cited by 275
Sasai, K., Katayama, H., Stenoien, D. L., Fujii, S., Honda, R., Kimura, M., Okano, Y., Tatsuka, M., Suzuki, F., Nigg, E. A., et al. (2004) · Cell Motility · doi:10.1002/cm.20039 · Cited by 270
Synthesis of Chalcones with Anticancer Activities
Syam, S., Abdelwahab, S. I., Al-Mamary, M. A., & Mohan, S. (2012) · Molecules · doi:10.3390/molecules17066179 · Cited by 261
Mahapatra, D. K., Asati, V., & Bharti, S. K. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.01.051 · Cited by 253
Self-citationTHE PROTEASOME AND PROTEASOME INHIBITORS IN CANCER THERAPY
Voorhees, P. M., & Orlowski, R. Z. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141300 · Cited by 247
Lane, D. P., Cheok, C. F., & Lain, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001222 · Cited by 246
Wang, Z., Wang, N., Han, S., Wang, D., Mo, S., Yu, L., Huang, H., Tsui, K., Shen, J., & Chen, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068566 · Cited by 233
Hsp90 Regulates Androgen Receptor Hormone Binding Affinity in Vivo
Fang, Y., Fliss, A. E., Robins, D. M., & Caplan, A. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28697 · Cited by 227
Overview of P-glycoprotein inhibitors: a rational outlook
Srivalli, K. M. R., & Lakshmi, P. K. (2012) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502012000300002 · Cited by 225
Braulio Insuasty, O., Tigreros, A., Orozco, F., Jairo Quiroga, P., Abonía, R., Nogueras, M., Sánchez, A., & Cobo, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.06.013 · Cited by 212
Anticancer Potential of Plants and Natural Products: A Review
Prakash, O., Kumar, A., Kumar, P., & Ajeet, A. (2013) · American Journal of Pharmacological Sciences · doi:10.12691/ajps-1-6-1 · Cited by 212
A Cathepsin K Inhibitor Reduces Breast Cancer–Induced Osteolysis and Skeletal Tumor Burden
Le Gall, C., Bellahcène, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J., & Clézardin, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3940 · Cited by 204
Lindqvist, A., Källström, H., Lundgren, A., Barsoum, E., & Rosenthal, C. K. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503066 · Cited by 200
ISRAF, D., KHAIZURIN, T., SYAHIDA, A., LAJIS, N., & KHOZIRAH, S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.04.025 · Cited by 190
Pandey, M. K., Sandur, S. K., Sung, B., Sethi, G., Kunnumakkara, A. B., & Aggarwal, B. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700890200 · Cited by 189
Duffy, A. M., Bouchier‐Hayes, D. J., & Harmey, J. H. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9148-5_13 · Cited by 189
Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727
Zhang, Q., Raje, V., Yakovlev, V. A., Yacoub, A., Szczepanek, K., Meier, J., Derecka, M., Chen, Q., Hu, Y., Sisler, J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.505057 · Cited by 188
1,2,3-Triazole tethered β-lactam-Chalcone bifunctional hybrids: Synthesis and anticancer evaluation
Singh, P., Raj, R., Kumar, V., Mahajan, M. P., Bedi, P. M. S., Kaur, T., & Saxena, A. K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.033 · Cited by 177
Antimitotic and Antiproliferative Activities of Chalcones: Forward Structure–Activity Relationship
Boumendjel, A., Boccard, J., Carrupt, P.-A., Nicolle, E., Blanc, M., Geze, A., Choisnard, L., Wouessidjewe, D., Matera, E.-L., & Dumontet, C. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0708331 · Cited by 176
Hoeflich, K. P., Herter, S., Tien, J., Wong, L., Berry, L., Chan, J., O'Brien, C., Modrusan, Z., Seshagiri, S., Lackner, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3563 · Cited by 174
Harikumar, K. B., Kunnumakkara, A. B., Ahn, K. S., Anand, P., Krishnan, S., Guha, S., & Aggarwal, B. B. (2009) · Blood · doi:10.1182/blood-2008-04-151944 · Cited by 167
Hsu, Y. L., Kuo, P. L., Tzeng, W. S., & Lin, C. C. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.10.003 · Cited by 166
Asati, V., Mahapatra, D. K., & Bharti, S. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.025 · Cited by 165
Self-citationVarma, M. V. S., Sateesh, K., & Panchagnula, R. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0499196 · Cited by 161
Functional Genomics Identifies TOR-Regulated Genes that Control Growth and Division
Guertin, D. A., Guntur, K. V. P., Bell, G. W., Thoreen, C. C., & Sabatini, D. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.03.084 · Cited by 158
Isobavachalcone, a Chalcone Constituent of Angelica keiskei, Induces Apoptosis in Neuroblastoma
Nishimura, R., Tabata, K., Arakawa, M., Ito, Y., Kimura, Y., Akihisa, T., Nagai, H., Sakuma, A., Kohno, H., & Suzuki, T. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1878 · Cited by 157
The epidemiology of EBV and its association with malignant disease
Hjalgrim, H., Friborg, J., & Melbye, M. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.054 · Cited by 154
Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
Wong, K. (2008) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489209787002461 · Cited by 154
The role of Epstein–Barr virus in cancer
Pattle, S. B., & Farrell, P. J. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.11.1193 · Cited by 154
Structural Antitumoral Activity Relationships of Synthetic Chalcones
Echeverría, C., Santibanez, J. F., Donoso‐Tauda, O., Escobar, C. A., & Ramírez‐Tagle, R. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10010221 · Cited by 151
Mai, C., Yaeghoobi, M., Abd-Rahman, N., Kang, Y. B., & Pichika, M. R. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.002 · Cited by 151
Kamal, A., Prabhakar, S., Ramaiah, M. J., Reddy, P. V., Reddy, C. R., Mallareddy, A., Shankaraiah, N., Reddy, T. L. N., Pushpavalli, S. N. C. V. L., & Pal‐Bhadra, M. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.050 · Cited by 146
Vascular endothelial growth factor receptor‐2: Its unique signaling and specific ligand, VEGF‐E
Shibuya, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01514.x · Cited by 146
Li, X., Sakashita, G., Matsuzaki, H., Sugimoto, K., Kimura, K., Hanaoka, F., Taniguchi, H., Furukawa, K., & Urano, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403029200 · Cited by 142
Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity
Abonía, R., Insuasty, D., Castillo, J., Braulio Insuasty, O., Jairo Quiroga, P., Nogueras, M., & Cobo, J. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.08.039 · Cited by 140
Cytotoxic chalcones and antioxidants from the fruits of Syzygium samarangense (Wax Jambu)
Simirgiotis, M. J., Adachi, S., To, S., Yang, H., Reynertson, K. A., Basile, M. J., Gil, R. R., Weinstein, I. B., & Kennelly, E. J. (2007) · Food Chemistry · doi:10.1016/j.foodchem.2007.08.086 · Cited by 138
Pratt, W. B. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90198-h · Cited by 123
Yun, J., Kweon, M., Kwon, H., Hwang, J., & Mukhtar, H. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi348 · Cited by 123
Wang, G., Li, C., He, L., Lei, K., Wang, F., Pu, Y., Yang, Z., Cao, D., Ma, L., Chen, J., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.028 · Cited by 115
Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells
Wang, K.-L., Hsia, S., Chan, C.-J., Chang, F.-Y., Huang, C., Bau, D., & Wang, P. S. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.756869 · Cited by 111
Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities
Bail, J.-C. L., Pouget, C., Fagnère, C., Basly, J. P., Chulia, A.-J., & Habrioux, G. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00974-7 · Cited by 109
Wu, W., Ye, H., Wan, L., Han, X., Wang, G., Hu, J., Tang, M., Duan, X., Fan, Y., He, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt087 · Cited by 108
Valdameri, G., Gauthier, C., Terreux, R., Kachadourian, R., Day, B. J., Winnischofer, S. M. B., Rocha, M. E. M., Martel‐Frachet, V., Ronot, X., Pietro, A. D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2016528 · Cited by 101
Anti-angiogenic and Anti-tumor Activities of 2'-Hydroxy-4'-methoxychalcone
Lee, Y. S., Lim, S. S., Shin, K. H., Kim, Y. S., Ohuchi, K., & Jung, S. H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1028 · Cited by 96
Liu, X., Tee, H.-W., & Go, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.006 · Cited by 95
Kuete, V., Nkuété, A. H. L., Mbaveng, A. T., Wiench, B., Wabo, H. K., Tane, P., & Efferth, T. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.08.001 · Cited by 94
BRAF and KRAS mutations in prostatic adenocarcinoma
Cho, N., Choi, M., Kim, B., Cho, Y., Moon, K. C., & Kang, G. H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22071 · Cited by 94
Natural chalcones as dual inhibitors of HDACs and NF-κB
Orlikova, B., Schnekenburger, M., Zloh, M., Golais, F., Diederich, M. F., & Taşdemir, D. (2012) · Oncology Reports · doi:10.3892/or.2012.1870 · Cited by 93
Aly, M. R. E., Fodah, H. H. A. E. R., & Saleh, S. Y. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.021 · Cited by 92
2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells
Kim, S. Y., Lee, I., & Moon, A. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.03.012 · Cited by 91
Ji, T., Lin, C. H., Krill, L. S., Eskander, R. H., Guo, Y., Zi, X., & Hoang, B. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-55 · Cited by 91
Boumendjel, A., Leer, A. M., Champelovier, P., Allegro, D., Muhammad, D., Souard, F., Derouazi, M., Peyrot, V., Toussaint, B., & Boutonnât, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-242 · Cited by 89
The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4
Kerr, D. J., Hamel, E., Jung, M. K., & Flynn, B. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.006 · Cited by 87
Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors
Salum, L. B., Altei, W. F., Chiaradia, L. D., Cordeiro, M. N. S., Canevarolo, R. R., Melo, C. P. D. S., Winter, E., Mattei, B., Daghestani, H. N., Santos‐Silva, M. C., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.02.037 · Cited by 84
Samoszuk, M. K., Tan, J., & Chorn, G. (2005) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-5-5 · Cited by 83
Issaenko, O. A., & Amerik, A. Y. (2012) · Cell Cycle · doi:10.4161/cc.20174 · Cited by 83
Ahmad, A., Sarkar, S. H., Aboukameel, A., Ali, S., Biersack, B., Seibt, S., Li, Y., Bao, B., Kong, D., Banerjee, S., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs290 · Cited by 82
Inhibition of IκB Kinase-β and Anticancer Activities of Novel Chalcone Adamantyl Arotinoids
Lorenzo, P., Álvarez, R., Ortiz, M. A., Álvarez, S., Piedrafita, F. J., & de Lera, Á. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800285f · Cited by 79
Matrix metalloproteinases – an overview
Sekton, B. (2010) · Research and Reports in Biology · doi:10.2147/rrb.s12043 · Cited by 73
Antitumor and antimetastatic effects of licochalcone A in mouse models
Kim, J., Shin, E. K., Park, J. H., Kim, Y. H., & Park, J. H. Y. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0625-2 · Cited by 72
Ruan, B., Lu, X., Tang, J.-F., Wei, Y., Wang, X.-L., Zhang, Y., Wang, L., & Zhu, H. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.001 · Cited by 71
Ngameni, B., Touaibia, M., Patnam, R., Belkaid, A., Sonna, P., Ngadjui, B. T., Annabi, B., & Roy, R. (2006) · Phytochemistry · doi:10.1016/j.phytochem.2006.09.017 · Cited by 67
Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation
Mielcke, T. R., Mascarello, A., Filippi‐Chiela, E. C., Zanin, R. F., Lenz, G., Leal, P. C., Chirardia, L. D., Yunes, R. A., Nunes, R. J., Battastini, A. M. O., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.12.023 · Cited by 66
Wang, L., Chen, G., Lu, X., Wang, S., Han, S., Li, Y., Ping, G., Jiang, X., Li, H., Yang, J., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.036 · Cited by 64
Matrix Metalloproteinases: An Overview
Nagase, H., & Visse, R. (2009) · Wiley eBooks · doi:10.1002/9780470508169.ch23 · Cited by 60
Synthesis and in vitro biological evaluation of dihydroartemisinyl-chalcone esters
Smit, F. J., van Biljon, R., Birkholtz, L., & N’Da, D. D. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.016 · Cited by 59
Yuan, X., Li, T., Xiao, E.-L., Zhao, H., Li, Y., Fu, S., Gan, L., Wang, Z., Zheng, Q., & Wang, Z. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.12.030 · Cited by 55
Lin, T. P., Guzman, R. C., Osborn, R. C., Thórdarson, G., & Nandi, S. (1992) · PubMed · Cited by 52
Quinolinyl and quinolinyl N-oxide chalcones: Synthesis, antifungal and cytotoxic activities
Tavares, L. D. C., Johann, S., Alves, T. M. D. A., Guerra, J. C., de Souza-Fagundes, E. M., Cisalpino, P. S., Bortoluzzi, A. J., Caramori, G. F., Piccoli, R. D. M., Braibante, H. T. S., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.019 · Cited by 50
STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin?
Jr., R. H. B. (2009) · CRC Press eBooks · doi:10.1201/9781498713764-13 · Cited by 50
Seidel, C., Schnekenburger, M., Zwergel, C., Gaascht, F., Mai, A., Dicato, M. A., Kirsch, G., Valente, S., & Diederich, M. F. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.067 · Cited by 48
Microtubular structure and tubulin polymerization
Mandelkow, E., & Mandelkow, E.-M. (1990) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(05)80023-7 · Cited by 48
Marković, V. R., Debeljak, N., Stanojković, T., Kolundžija, B., Sladić, D. M., Vujčić, M. T., Janović, B. S., Tanić, N., Perović, M., Tešić, V., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.055 · Cited by 47
Kantevari, S., Addla, D., Bagul, P. K., Sridhar, B., & Banerjee, S. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.085 · Cited by 47
Kahyo, T., Ichikawa, S., Hatanaka, T., Yamada, M. K., & Setou, M. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08203fp · Cited by 47
Parveen, Z., Brunhofer, G., Jabeen, I., Erker, T., Chiba, P., & Ecker, G. F. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.005 · Cited by 44
Yang, X., Wang, W., Tan, J., Song, D., Li, M., Liu, D., Jing, Y., & Zhao, L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.076 · Cited by 44
Design, synthesis and anticancer activity of nitric oxide donating/chalcone hybrids
Mourad, M. A. E., Abdel‐Aziz, M., Abuo‐Rahma, G. E. A., & Farag, H. H. A. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.05.030 · Cited by 43
Rao, Y. K., Kao, T.-Y., Ko, J., & Tzeng, Y. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.056 · Cited by 41
Gu, X., Ren, Z., Tang, X., Peng, H., Yuan-fang Ma, A., Lai, Y., Peng, S., & Zhang, Y. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.050 · Cited by 40
Mouse models for BRAF-induced cancers
Pritchard, C. A., Carragher, L., Aldridge, V., Giblett, S. M., Jin, H., Foster, C., Andreadi, C., & Kamata, T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351329 · Cited by 39
Li, Q., Li, C., Lu, X., Zhang, H., & Zhu, H. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.007 · Cited by 38
Chung, C., Chang, C.-H., Chen, S.-S., Wang, H.-H., Yen, J.-Y., Hsiao, C., Wu, N., Chen, Y., Huang, T., Wang, P., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/943187 · Cited by 37
Macrophage Matrix Metalloproteinase-9 Regulates Angiogenesis in Ischemic Muscle
Bendeck, M. P. (2004) · Circulation Research · doi:10.1161/01.res.0000117525.23089.1a · Cited by 35
Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth
Mizuno, C. S., Paul, S., Suh, N., & Rimando, A. M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.038 · Cited by 33
Warmka, J. K., Solberg, E. L., Zeliadt, N. A., Srinivasan, B., Charlson, A. T., Xing, C., & Wattenberg, E. V. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.140 · Cited by 32
In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid
Loch-Neckel, G., Bicca, M. A., Leal, P. C., Mascarello, A., Siqueira, J. M., & Calixto, J. Β. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.014 · Cited by 30
Sasayama, T., Tanaka, K., Mizukawa, K., Kawamura, A., Kondoh, T., Hosoda, K., & Kohmura, E. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9395-2 · Cited by 30
Rodrigues, J. R., Abramjuk, C., Vásquez, L., Gamboa, N., Domínguez, J. N., Nitzsche, B., Höpfner, M., Georgieva, R. T., Bäumler, H., Stephan, C., et al. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0347-8 · Cited by 29
Methoxychalcone inhibitors of androgen receptor translocation and function
Kim, Y. S., Kumar, V., Lee, S., Iwai, A., Neckers, L., Malhotra, S. V., & Trepel, J. B. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.141 · Cited by 29
Reddy, M. V. B., Shen, Y., Yang, J., Hwang, T., Bastow, K. F., Qian, K., Lee, K., & Wu, T.-S. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.004 · Cited by 27
Pinz, S., Unser, S., Brueggemann, S., Besl, E., Al-Rifai, N. M., Petkes, H., Amslinger, S., & Rascle, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090275 · Cited by 27
Microtubular structure and tubulin polymerization
Mandelkow�, E., & Mandelkow�, E. (1989) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(89)80029-8 · Cited by 27
Wu, C.-M., Lin, K., Teng, C.-H., Huang, A., Chen, C. Y., Yen, M., Wu, W., Pu, Y., & Lin, C. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00099 · Cited by 24
Henmi, K., Hiwatashi, Y., Hikita, E., Toyama, N., & Hirano, T. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1109 · Cited by 21
5α-Reductase inhibitory component from leaves ofArtocarpus altilis
Shimizu, K., Kondo, R., Sakai, K., Buabarn, S., & Dilokkunanant, U. (2000) · Journal of Wood Science · doi:10.1007/bf00776401 · Cited by 13
Sun, Y., Huang, W., Hsiao, C., Chen, Y., Lu, P., & Guh, J. (2010) · The Prostate · doi:10.1002/pros.21165 · Cited by 13
Kim, Y. G., Ramachandran, S., Kim, D.-C., Hong, Y. B., Kim, E. H., Kwon, S., Shin, S., Cha, S.-D., Bae, I., & Cho, C. (2010) · Journal of Women s Medicine · doi:10.5468/jwm.2010.3.3.89 · Cited by 9
(1998) · doi:10.1002/(sici)1521-1878(199808)20:8<615::aid-bies4>3.0.co;2-h
Cited by
Chalcone: A Privileged Structure in Medicinal Chemistry
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00020 · Cited by 1,463
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Tetrazoles via Multicomponent Reactions
Neochoritis, C. G., Zhao, T., & Dömling, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00564 · Cited by 599
Current developments of coumarin-based anti-cancer agents in medicinal chemistry
Emami, S., & Dadashpour, S. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.08.033 · Cited by 504
Chalcone Derivatives: Role in Anticancer Therapy
Ouyang, Y., Li, J., Chen, X., Fu, X., Sun, S., & Wu, Q. (2021) · Biomolecules · doi:10.3390/biom11060894 · Cited by 399
Metadata
- Authors
- Mahapatra, D. K., Bharti, S. K., & Asati, V.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 98
- Pages
- 69-114
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2183025438
- Cited by
- 495
- References
- 158
- FWCI
- 23.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.